CPA
ABBV icon

Cathy Pareto & Associates’s AbbVie ABBV Stock Holding History

Cathy Pareto & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$386K Sell
1,534
-3
-0.2% -$645 0.23% 66
2026
Q1 		$334K Sell
1,537
-138
-8% -$30.6K 0.22% 68
2025
Q4 		$383K Sell
1,675
-71
-4% -$16.2K 0.27% 64
2025
Q3 		$404K Buy
1,746
+38
+2% +$7.74K 0.31% 58
2025
Q2 		$317K Buy
1,708
+14
+0.8% +$2.6K 0.26% 70
2025
Q1 		$355K Sell
1,694
-105
-6% -$20.4K 0.31% 62
2024
Q4 		$320K Buy
+1,799
New +$331K 0.29% 63

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
KeyBank National Association
KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

Cathy Pareto & Associates's ABBV Position: Q2 2026 in Review

Cathy Pareto & Associates reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $645 and leaving 1,534 shares worth $386K. The position accounts for 0.23% of the portfolio, ranked #66.

Cathy Pareto & Associates first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $404K in Q3 2025. 1,660 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cathy Pareto & Associates held 1,534 shares of AbbVie worth $386K as of Q2 2026.
  • Cathy Pareto & Associates sold 3 AbbVie shares in Q2 2026, an estimated $645.
  • AbbVie made up 0.23% of Cathy Pareto & Associates's portfolio in Q2 2026, its #66 holding.
  • Cathy Pareto & Associates first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • Cathy Pareto & Associates's AbbVie position peaked at $404K in Q3 2025.
  • 1,660 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cathy Pareto & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.